Page 16 of 17
PA15.1-3 | Macrocytic Anemias & B12/Folate — Case Study
CLINICAL SCENARIO
A real-world diagnostic challenge: an elderly patient with macrocytic anaemia and subtle neurological signs. Your task is to work through the clinical features, interpret the blood picture, select confirmatory tests, distinguish B12 from folate deficiency, and outline management — integrating your knowledge of one-carbon metabolism (SDL1), the haematological changes of megaloblastic anaemia (SDL2), and peripheral smear interpretation (SDL3).
Instructions
Read the clinical vignette below carefully, then complete each of the six scaffolded sections in sequence. Use full sentences and appropriate medical terminology. Cite relevant pathophysiological mechanisms, not just conclusions. Your response will be peer-reviewed by a classmate; reviewers assess both scientific accuracy and the quality of your clinical reasoning.
Clinical Vignette
Mr. Rajesh Kumar, a 68-year-old lacto-vegetarian retired schoolteacher, presents to the medicine OPD with a 4-month history of progressive fatigue, mild dyspnoea on exertion, and a tingling sensation in both feet. His daughter notes he has become increasingly forgetful over the last 2 months. He had a subtotal gastrectomy 12 years ago for a peptic ulcer and takes no regular medications. He denies alcohol use. He eats no meat, fish, or eggs. On examination: pallor +++, slight jaundice of sclerae, beefy-red tongue, and reduced vibration sense in both lower limbs up to the knees. Romberg's sign is positive.
Investigations on admission:
| Parameter | Result | Reference range |
|---|---|---|
| Haemoglobin | 7.2 g/dL | 13–17 |
| MCV | 118 fL | 80–100 |
| MCH | 38 pg | 27–33 |
| WBC | 3.8 × 10⁹/L | 4–11 |
| Platelets | 98 × 10⁹/L | 150–400 |
| Reticulocyte count | 0.4% | 0.5–2.0 |
| Serum LDH | 980 U/L | 140–280 |
| Serum bilirubin (indirect) | 2.8 mg/dL | <1.2 |
The peripheral blood smear report reads: "Macro-ovalocytes, anisocytosis, poikilocytosis. Hypersegmented neutrophils (5–6 lobes) noted. Occasional teardrop cells. Thrombocytopenia. Erythropoiesis appears megaloblastic."
Length: Total 1,200–1,500 words across all sections. The allocation per section is a guide; prioritise depth over word count in sections 3 and 4, which carry the highest rubric weighting.
What to Submit
Section 1 — Clinical Feature Analysis
Identify and explain the key clinical and laboratory findings in Mr. Kumar's case. For each finding, provide a brief pathophysiological basis. Specifically address: (a) why his MCV is elevated, (b) the mechanism of his indirect hyperbilirubinaemia and raised LDH, (c) the significance of pancytopenia in this context, and (d) the neurological findings — which anatomical pathways are involved and how does B12 deficiency cause this picture?
Guidance: Aim for ~250 words. Structure your answer point-by-point. Demonstrate that you understand why each finding occurs, not just that it occurs. Connect megaloblastic bone marrow changes (ineffective erythropoiesis, intramedullary haemolysis) to the lab values. For the neurology, name the tract(s) affected in subacute combined degeneration.
Section 2 — Blood Picture Interpretation
Interpret the peripheral blood smear findings systematically. (a) Define macro-ovalocytes and explain how they arise in megaloblastic anaemia (link to impaired DNA synthesis and nuclear-cytoplasmic dissociation). (b) What is the diagnostic significance of hypersegmented neutrophils — how many lobes, and how many cells, constitute a positive finding? (c) Why is the reticulocyte count paradoxically low despite severe anaemia? (d) Correlate the smear findings with the MCV, MCH, and RDW changes you would expect.
Guidance: ~200 words. Be precise about diagnostic thresholds (e.g., ≥5 lobes in ≥5% of neutrophils, or any cell with ≥6 lobes). Explain the concept of nuclear-cytoplasmic dissociation. Note that teardrop cells (dacryocytes) here suggest marrow stress, not myelofibrosis — briefly differentiate.
Section 3 — Confirmatory Investigation Strategy
Design an evidence-based investigation plan to confirm the diagnosis and identify the specific deficiency. List the tests in logical sequence and justify each: (a) first-line tests (serum B12, serum folate, RBC folate — which is preferred and why?), (b) functional markers of deficiency (methylmalonic acid, homocysteine — distinguish their utility in differentiating B12 vs folate deficiency), (c) tests to identify the cause of the deficiency in this patient specifically (anti-intrinsic factor antibodies, anti-parietal cell antibodies, Schilling test rationale, upper GI endoscopy considerations given his gastrectomy history), and (d) a bone marrow biopsy — is it required here? Justify your answer.
Guidance: ~250 words. Address each point systematically. Note that serum folate is unstable and RBC folate better reflects tissue stores. Explain why MMA is elevated in B12 deficiency but not in isolated folate deficiency — link to the methylmalonyl-CoA mutase pathway. Schilling test is no longer widely available — note its historical role without implying it is the current standard.
Section 4 — B12 vs Folate Deficiency: Differential Reasoning
Construct a differential diagnosis framework distinguishing vitamin B12 deficiency from folate deficiency in this patient. Address: (a) which deficiency is more likely in Mr. Kumar, and list at least three specific risk factors from the history that support this, (b) complete the table: for each of the following parameters state whether it is elevated, reduced, or normal in B12 deficiency alone vs folate deficiency alone — serum MMA, serum homocysteine, neurological manifestations, response to folate therapy alone, (c) the 'methylfolate trap' — explain the biochemical mechanism in one or two clear sentences linking impaired methionine synthesis to the functional folate deficiency seen in B12 depletion.
Guidance: ~250 words. Risk factors to identify: lacto-vegetarianism (zero dietary B12), subtotal gastrectomy (loss of parietal cells → intrinsic factor deficiency), elderly age (achlorhydria, gastric atrophy). The 'folate trap' is a key conceptual point from SDL1 — if the student misses it, the differential reasoning will be incomplete. Warn students: prescribing folate alone to a B12-deficient patient may correct anaemia but unmask or worsen neurological damage.
Section 5 — Management Plan
Outline an evidence-based management plan for Mr. Kumar. Structure your answer as: (a) immediate — route, dose, and frequency of B12 replacement in a patient with malabsorption; justify the parenteral route, (b) monitoring — which parameters confirm response, and what is the expected reticulocyte peak timing? (c) adjunctive measures — folate supplementation (yes/no, with rationale), iron supplementation (yes/no — explain why serum iron may fall after B12 therapy begins), (d) disease-specific management — what is the implication of the gastrectomy for long-term supplementation, and what would change if anti-IF antibodies are positive (pernicious anaemia)? (e) neurological follow-up — is reversal of subacute combined degeneration expected, and on what timeline?
Guidance: ~200 words. Standard dosing: hydroxocobalamin 1 mg IM daily × 7, then weekly × 4, then monthly for life (or indefinitely if dietary). Reticulocyte peak at day 5–7. Note the 'hunger' phenomenon: ferritin and iron may drop as the marrow rebounds — pre-emptive iron supplementation is debated but may be needed. Neurological recovery is slower and often incomplete if damage has been longstanding; demyelination takes months to years to reverse.
Section 6 — Reflection & Broader Synthesis
Reflect on the diagnostic journey in this case. (a) What was the single most diagnostically important feature that should have triggered consideration of B12 deficiency even before the blood results? (b) How might this presentation differ in a patient with folate deficiency due to chronic alcoholism rather than B12 deficiency? List two key differences. (c) If Mr. Kumar's serum B12 level came back borderline-low (normal 180–900 pg/mL; his result: 195 pg/mL), would you treat empirically? What additional tests would guide your decision? (d) What is the public health or community-practice lesson this case highlights for vegetarian populations in India?
Guidance: ~150 words. Encourage genuine reflection, not just factual recall. The 'most important feature' answer could legitimately be the neurological signs (absence in folate deficiency) or the gastrectomy history — both are acceptable if justified. For borderline B12, MMA and homocysteine are the discriminating functional tests. The public health angle links to the high prevalence of B12 deficiency in South Asian vegetarian populations and the case for food fortification.
Grading Rubric — Macrocytic Anaemia Case Workup Rubric (Peer Review)
| Criterion | Points | Full-marks descriptor |
|---|---|---|
| Clinical Feature Analysis — Pathophysiological accuracy and completeness (Sections 1 & 2) | 8 pts | All key findings accurately explained with precise mechanisms (ineffective erythropoiesis, intramedullary haemolysis, impaired thymidylate synthesis, posterior/lateral column demyelination). Hypersegmented neutrophil threshold cited correctly. Reticulocyte paradox and smear-to-indices correlation fully addressed. |
| Confirmatory Investigation Strategy — Logical sequence, correct test selection, and justified reasoning (Section 3) | 7 pts | Logical tiered investigation plan. RBC folate correctly preferred over serum folate with justification. MMA and homocysteine roles precisely distinguished (MMA elevated in B12 deficiency only). Cause-specific tests correctly identified for this patient (anti-IF antibody, parietal cell antibody, GI endoscopy rationale). Bone marrow biopsy indication correctly assessed — not required here, with sound justification. |
| B12 vs Folate Differential Reasoning — Biochemical mechanism and clinical discrimination (Section 4) | 7 pts | Three or more specific risk factors correctly identified. MMA/homocysteine/neurological/folate-therapy comparison table completed accurately. Methylfolate trap explained with correct biochemical mechanism (impaired methionine synthase → THF cannot be regenerated → functional folate deficiency). Folate-monotherapy danger clearly articulated. |
| Management Plan — Evidence-based, patient-specific, and complete (Section 5) | 5 pts | Parenteral B12 route correctly justified (malabsorption due to gastrectomy/IF loss). Correct dosing schedule stated. Reticulocyte peak timing cited (day 5–7). Iron-fall phenomenon after marrow rebound addressed. Pernicious anaemia implication of anti-IF antibodies addressed. Realistic timeline for neurological recovery with appropriate caveats. |
| Reflection & Critical Reasoning Quality (Section 6) | 3 pts | Insightful, genuine reflection. Distinguishing feature from history or neurology correctly prioritised. Alcoholic folate deficiency vs B12 differences clearly stated (no neurological signs in folate deficiency; alcohol-specific history, dietary pattern). Borderline B12 management correctly resolved with MMA/homocysteine. Public health dimension addressed with contextual specificity (India, vegetarian population, fortification). |
PEER REVIEW
You will review your classmate's case workup after submitting your own. Use the rubric criteria above as your guide.
What to do:
1. Read their response without looking at the rubric first. Note your overall impression.
2. Then assess each rubric criterion and assign a score with a brief justification (1–2 sentences per criterion).
3. Write one paragraph of constructive feedback highlighting the strongest aspect of their reasoning.
4. Write one paragraph identifying the most significant gap or error, and suggest how they could improve it.
5. Be specific — reference mechanisms, test names, or clinical findings from the vignette rather than giving generic praise.
What to avoid:
- Do not simply validate your classmate's answer because it resembles your own. Think critically.
- Avoid superficial comments ('Good job', 'Well written') without substantive reasoning.
- Do not penalise reasonable alternative approaches if they are medically defensible.
Word limit for peer review: 200–350 words.